NCT00252005 Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study Status COMPLETED Phase PHASE2
NCT00251498 Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00251485 A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00251446 A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00251186 First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients Status TERMINATED Phase PHASE2
NCT00250705 Trial of Aripiprazole in the Treatment of CD in Adolescents Status COMPLETED Phase PHASE4
NCT00249873 Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A) Status COMPLETED Phase PHASE3
NCT00249795 Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) Status COMPLETED Phase PHASE3
NCT00246987 A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control Status COMPLETED Phase PHASE3
NCT00245388 Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia Status COMPLETED Phase PHASE2/PHASE3
NCT00243178 Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) Status TERMINATED Phase PHASE3
NCT00240370 A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics Status COMPLETED Phase PHASE3
NCT00237471 Impact of Tight Glycaemic Control in Acute Myocardial Infarction Status TERMINATED Phase PHASE4
NCT00235222 Evaluation of Viral Efficacy and Safety of a Reduced Dose of Stavudine (d4T): THE PHOENIX STUDY Status UNKNOWN Phase PHASE4
NCT00232505 Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2